Patent · US Expired

Anti-angiogenic agent and method for inhibiting angiogenesis

US6465424B1 · kind B1 · utility

0Cited by
9References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2000
Grant dateOct 15, 2002
Priority date
Expiry dateJan 17, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions that inhibit the proliferation and migration of endothelial cells. The compositions contain a pre-activation domain (“PAD”) from plasminogen, or a biologically active fragment thereof, and at least one kringle region from plasminogen, or a biologically active portion thereof. The compositions are useful to treat angiogenic associated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.